PHIBRO ANIMAL HEALTH CORP-A (PAHC) Stock Price, Quote, News and Overview
NASDAQ:PAHC - Nasdaq - US71742Q1067 - Common Stock - Currency: USD
PAHC Quote, Performance and Key Statistics
17.29
+0.46 (+2.73%)
The current stock price of PAHC is 17.29 USD. In the past month the price decreased by -20.72%. In the past year, price increased by 30%.
PAHC Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 64.61 | 796.27B | ||
| JNJ | JOHNSON & JOHNSON | 15.67 | 379.48B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 16.83 | 257.82B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.96 | 218.96B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 16.29 | 209.55B | ||
| MRK | MERCK & CO. INC. | 10.21 | 196.28B | ||
| PFE | PFIZER INC | 7.12 | 125.57B | ||
| SNY | SANOFI-ADR | 11.41 | 124.61B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 43.18 | 100.17B | ||
| GSK | GSK PLC-SPON ADR | 8.32 | 72.88B | ||
| ZTS | ZOETIS INC | 25.11 | 66.32B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.98 | 46.47B |
Related stock screener links
About PAHC
Company Profile
Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. The company is headquartered in Teaneck, New Jersey and currently employs 1,940 full-time employees. The company went IPO on 2014-04-11. The company develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. The company markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. The company has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Company Info
PHIBRO ANIMAL HEALTH CORP-A
Glenpointe Centre East, 3Rd Floor, 300 Frank W. Burr Blvd., Suite 21
Teaneck NEW JERSEY 07666 US
CEO: Jack C. Bendheim
Employees: 1940
Company Website: https://www.pahc.com/
Investor Relations: https://investors.pahc.com
Phone: 12013297300
PHIBRO ANIMAL HEALTH CORP-A / PAHC FAQ
What is the stock price of PHIBRO ANIMAL HEALTH CORP-A today?
The current stock price of PAHC is 17.29 USD. The price increased by 2.73% in the last trading session.
What is the ticker symbol for PHIBRO ANIMAL HEALTH CORP-A stock?
The exchange symbol of PHIBRO ANIMAL HEALTH CORP-A is PAHC and it is listed on the Nasdaq exchange.
On which exchange is PAHC stock listed?
PAHC stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for PHIBRO ANIMAL HEALTH CORP-A stock?
8 analysts have analysed PAHC and the average price target is 24.99 USD. This implies a price increase of 44.53% is expected in the next year compared to the current price of 17.29. Check the PHIBRO ANIMAL HEALTH CORP-A stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is PHIBRO ANIMAL HEALTH CORP-A worth?
PHIBRO ANIMAL HEALTH CORP-A (PAHC) has a market capitalization of 700.25M USD. This makes PAHC a Small Cap stock.
How many employees does PHIBRO ANIMAL HEALTH CORP-A have?
PHIBRO ANIMAL HEALTH CORP-A (PAHC) currently has 1940 employees.
What are the support and resistance levels for PHIBRO ANIMAL HEALTH CORP-A (PAHC) stock?
PHIBRO ANIMAL HEALTH CORP-A (PAHC) has a support level at 17.28 and a resistance level at 20.51. Check the full technical report for a detailed analysis of PAHC support and resistance levels.
Is PHIBRO ANIMAL HEALTH CORP-A (PAHC) expected to grow?
The Revenue of PHIBRO ANIMAL HEALTH CORP-A (PAHC) is expected to grow by 27.51% in the next year. Check the estimates tab for more information on the PAHC EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy PHIBRO ANIMAL HEALTH CORP-A (PAHC) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PAHC, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PAHC, evaluating the profitability, health, valuation and growth aspects
- PHIBRO ANIMAL HEALTH CORP-A (PAHC) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PHIBRO ANIMAL HEALTH CORP-A (PAHC) Sales and EPS estimates to see what analysts future expectations are.
- PHIBRO ANIMAL HEALTH CORP-A (PAHC) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PHIBRO ANIMAL HEALTH CORP-A (PAHC) Insider and Institutional Ownership to learn about the owners and their transactions.
- PHIBRO ANIMAL HEALTH CORP-A (PAHC) Stock Chart to make your own analysis
- PHIBRO ANIMAL HEALTH CORP-A (PAHC) Latest news and press-releases to stay up to date.
Does PHIBRO ANIMAL HEALTH CORP-A (PAHC) stock pay dividends?
PHIBRO ANIMAL HEALTH CORP-A (PAHC) has a dividend yield of 2.71%. The yearly dividend amount is currently 0.48. Check the full fundamental report for a detailed analysis of PAHC dividend history, reliability and sustainability.
When does PHIBRO ANIMAL HEALTH CORP-A (PAHC) report earnings?
PHIBRO ANIMAL HEALTH CORP-A (PAHC) will report earnings on 2025-05-07, after the market close.
What is the Price/Earnings (PE) ratio of PHIBRO ANIMAL HEALTH CORP-A (PAHC)?
The PE ratio for PHIBRO ANIMAL HEALTH CORP-A (PAHC) is 10.74. This is based on the reported non-GAAP earnings per share of 1.61 and the current share price of 17.29 USD. Check the full fundamental report for a full analysis of the valuation metrics for PAHC.
What is the Short Interest ratio of PHIBRO ANIMAL HEALTH CORP-A (PAHC) stock?
The outstanding short interest for PHIBRO ANIMAL HEALTH CORP-A (PAHC) is 4.69% of its float. Check the ownership tab for more information on the PAHC short interest.
PAHC Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to PAHC. When comparing the yearly performance of all stocks, PAHC is one of the better performing stocks in the market, outperforming 82.59% of all stocks.
PAHC Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to PAHC. While PAHC belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
PAHC Financial Highlights
Over the last trailing twelve months PAHC reported a non-GAAP Earnings per Share(EPS) of 1.61. The EPS increased by 41.23% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.75% | ||
| ROA | 1.5% | ||
| ROE | 7.83% | ||
| Debt/Equity | 2.99 |
PAHC Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 45% to PAHC. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 65.64% and a revenue growth 27.51% for PAHC